Papers
3
Total Citations
136
H-Index
3
About
Kenneth Poels is a leading researcher in the field of real-time adaptive radiotherapy, with a primary focus on improving the dosimetric accuracy of cancer treatments for moving tumors. His work centers on the critical challenge of tracking dynamic targets—particularly in the lungs and liver—during stereotactic ablative body radiation therapy (SABR/SBRT). Poels’ major contributions include pioneering multi-institutional studies that compare the performance of advanced tracking systems, such as the robotic CyberKnife and the gimbal-based Vero, demonstrating that adaptive treatments significantly enhance precision over non-adaptive methods in the presence of patient-measured tumor motion. His most cited paper (95 citations) provides a comprehensive dosimetric comparison of real-time adaptive systems, establishing a benchmark for clinical accuracy across robotic, gimbaled, and couch tracking platforms. Poels also contributed to a first-of-its-kind SBRT platform for dynamic lung tumor tracking, addressing the risks of normal tissue injury and tumor miss. With a cumulative citation impact exceeding 130, his research is instrumental in guiding the clinical adoption of motion-adaptive radiotherapy, directly improving treatment outcomes for patients with extracranial cancers.
Research Focus
Key Achievements
Top Papers
- 1
- 2
- 3